# IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD

Study · id `cardio:ct-nct07746362` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07746362](<https://clinicaltrials.gov/study/NCT07746362>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07746362

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

## Technical summary

Registry record NCT07746362. Allocation not applicable; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT07746362, source copy `cardio:ctgov-nct07746362-2026-10-21`, retrieved 2026-10-31)
- Planned start: 2026-12 (anticipated) (ClinicalTrials.gov record NCT07746362, source copy `cardio:ctgov-nct07746362-2026-10-21`, retrieved 2026-10-31)
- Primary completion: 2027-09-30 (anticipated) (ClinicalTrials.gov record NCT07746362, source copy `cardio:ctgov-nct07746362-2026-10-21`, retrieved 2026-10-31)
- Completion: 2028-01-30 (anticipated) (ClinicalTrials.gov record NCT07746362, source copy `cardio:ctgov-nct07746362-2026-10-21`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07746362-2026-10-21`, retrieved 2026-10-31)

## The registry's words

- Brief title: IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD
- Acronym: HELIX-PAD
- Condition: Peripheral Artery Disease (PAD)
- Intervention (Device): IV-X Medical IVL System
- Lead sponsor: IVX Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: 6b50997958be07f26d590f1447133c08accd83694e74bfb9cb92500f5634d194
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
